Canine comparative oncology for translational radiation research

References

• Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, et al. 2010. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 37(8):4078–4101.
   PubMed Web of Science ®Google Scholar
• Bourhis J, Sozzi WJ, Jorge PG, Gaide O, Bailat C, Duclos F, Patin D, Ozsahin M, Bochud F, Germond J-F, et al. 2019. Treatment of a first patient with FLASH-radiotherapy. Radiother Oncol. 139:18–22.
   PubMed Web of Science ®Google Scholar
• Bräuer-Krisch E, Serduc R, Siegbahn E, Le Duc G, Prezado Y, Bravin A, Blattmann H, Laissue J. 2010. Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue. Mutation Rese Rev Mutation Res. 704(1-3):160–166.
   PubMed Web of Science ®Google Scholar
• Canter RJ, Grossenbacher SK, Foltz JA, Sturgill IR, Park JS, Luna JI, Kent MS, Culp WTN, Chen M, Modiano JF, et al. 2017. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. J Immunotherapy Cancer. 5(1):1–16.
   PubMed Web of Science ®Google Scholar
• Chargari C, Levy A, Paoletti X, Soria J-C, Massard C, Weichselbaum RR, Deutsch E. 2020. Methodological development of combination drug and radiotherapy in basic and clinical research. Clin Cancer Res. 26(18):4723–4736.
   PubMed Web of Science ®Google Scholar
• Clerc‐Renaud B, Gieger TL, LaRue SM, Nolan MW. 2021. Treatment of genitourinary carcinoma in dogs using nonsteroidal anti‐inflammatory drugs, mitoxantrone, and radiation therapy: a retrospective study. J Vet Internal Med. 35(2):1052–1061.
   PubMed Web of Science ®Google Scholar
• Coy J, Caldwell A, Chow L, Guth A, Dow S. 2017. PD-1 expression by canine T cells and functional effects of PD-1 blockade. Vet Comp Oncol. 15(4):1487–1502.
   PubMed Web of Science ®Google Scholar
• Cranmer-Sargison G, Crewson C, Davis W, Sidhu N, Kundapur V. 2015. Medical linear accelerator mounted mini-beam collimator: design, fabrication and dosimetric characterization. Phys Med Biol. 60(17):6991–7005.
   PubMed Web of Science ®Google Scholar
• Debreuque M, De Fornel P, David I, Delisle F, Ducerveau M-N, Devauchelle P, Thibaud J-L. 2020. Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013–2019). BMC Vet Res. 16(1):1–14.
   PubMed Web of Science ®Google Scholar
• Demaria S, Guha C, Schoenfeld J, Morris Z, Monjazeb A, Sikora A, Crittenden M, Shiao S, Khleif S, Gupta S, et al. 2021. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? J Immunother Cancer. 9(4):e002038.
   PubMed Web of Science ®Google Scholar
• Dolera M, Malfassi L, Pavesi S, Finesso S, Sala M, Carrara N, Marcarini S, Mazza G, Bianchi C, Urso G. 2016. Volumetric-modulated arc stereotactic radiotherapy for canine adrenocortical tumours with vascular invasion. J Small Anim Pract. 57(12):710–717.
   PubMed Web of Science ®Google Scholar
• Dow S. 2020. A role for dogs in advancing cancer immunotherapy research. Front Immunol. 10:2935.
   PubMed Web of Science ®Google Scholar
• Fan TM, Selting KA. 2018. Exploring the potential utility of pet dogs with cancer for studying radiation-induced immunogenic cell death strategies. Front Oncol. 8:680.
   PubMed Web of Science ®Google Scholar
• Farese JP, Milner R, Thompson MS, Lester N, Cooke K, Fox L, Hester J, Bova FJ. 2004. Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs. J Am Vet Med Assoc. 225(10):1567–1572.
   PubMed Web of Science ®Google Scholar
• Favaudon V, Caplier L, Monceau V, Pouzoulet F, Sayarath M, Fouillade C, Poupon M-F, Brito I, Hupé P, Bourhis J, et al. 2014. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med. 6(245):245ra93.
   PubMed Web of Science ®Google Scholar
• Forrest LJ, Chun R, Adams W, Cooley AJ, Vail DM. 2000. Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Inter Med. 14(6):578–582.
   PubMed Web of Science ®Google Scholar
• Fox‐Alvarez S, Shiomitsu K, Lejeune AT, Szivek A, Kubicek L. 2020. Outcome of intensity‐modulated radiation therapy‐based stereotactic radiation therapy for treatment of canine nasal carcinomas. Vet Radiol Ultrasound. 61(3):370–378.
   PubMed Web of Science ®Google Scholar
• Gagnon J, Mayer MN, Belosowsky T, Mauldin GN, Waldner CL. 2020. Stereotactic body radiation therapy for treatment of soft tissue sarcomas in 35 dogs. J Am Vet Med Assoc. 256(1):102–110.
   PubMed Web of Science ®Google Scholar
• Ghita M, Fernandez-Palomo C, Fukunaga H, Fredericia PM, Schettino G, Bräuer-Krisch E, Butterworth KT, McMahon SJ, Prise KM. 2018. Microbeam evolution: from single cell irradiation to pre-clinical studies. Int J Radiat Biol. 94(8):708–718.
   PubMed Web of Science ®Google Scholar
• Gieger T, Nolan M. 2018. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016). Vet Comp Oncol. 16(1):E68–E75.
   PubMed Web of Science ®Google Scholar
• Griffin L, Nolan M, Selmic L, Randall E, Custis J, LaRue S. 2016. Stereotactic radiation therapy for treatment of canine intracranial meningiomas. Vet Comp Oncol. 14(4):e158–e170.
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Prise KM, McMahon SJ, Zhang X, Penagaricano J, Butterworth KT. 2020. History and current perspectives on the biological effects of high-dose spatial fractionation and high dose-rate approaches: GRID, Microbeam & FLASH radiotherapy. Br J Radiol. 93(1113):20200217.
   PubMed Web of Science ®Google Scholar
• Guth AM, Hafeman SD, Elmslie RE, Dow SW. 2013. Liposomal clodronate treatment for tumour macrophage depletion in dogs with soft-tissue sarcoma. Vet Comp Oncol. 11(4):296–305.
   PubMed Web of Science ®Google Scholar
• Hanna GG, Murray L, Patel R, Jain S, Aitken KL, Franks KN, van As N, Tree A, Hatfield P, Harrow S, et al. 2018. UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol. 30(1):5–14.
   Google Scholar
• Hansen KS, Théon AP, Willcox JL, Stern JA, Kent MS. 2021. Long-term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart-base tumours in dogs. Vet Comp Oncol. 19(1):191–200.
   PubMed Web of Science ®Google Scholar
• Hansen KS, Zwingenberger AL, Théon AP, Kent MS. 2019. Long-term survival with stereotactic radiotherapy for imaging-diagnosed pituitary tumors in dogs. Vet Radiol Ultrasound. 60(2):219–232.
   PubMed Web of Science ®Google Scholar
• Henry CJ, Brewer WG, Jr Tyler JW, Brawner WR, Henderson RA, Hankes GH, Royer N. 1998. Survival in dogs with nasal adenocarcinoma: 64 cases (1981-1995). J Vet Intern Med. 12(6):436–439.
   PubMed Web of Science ®Google Scholar
• Hoopes PJ, Wagner RJ, Duval K, Kang K, Gladstone DJ, Moodie KL, Crary-Burney M, Ariaspulido H, Veliz FA, Steinmetz NF, et al. 2018. Treatment of canine oral melanoma with nanotechnology-based immunotherapy and radiation. Mol Pharm. 15(9):3717–3722.
   PubMed Web of Science ®Google Scholar
• Judge SJ, Yanagisawa M, Sturgill IR, Bateni SB, Gingrich AA, Foltz JA, Lee DA, Modiano JF, Monjazeb AM, Culp WTN, et al. 2020. Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer. PLoS One. 15(2):e0224775.
   PubMed Web of Science ®Google Scholar
• Kang J, Demaria S, Formenti S. 2016. Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer. 4(1):51.
   PubMed Web of Science ®Google Scholar
• Kent MS, Bommarito D, Feldman E, Theon AP. 2007. Survival, neurologic response, and prognostic factors in dogs with pituitary masses treated with radiation therapy and untreated dogs. J Vet Intern Med. 21(5):1027–1033.
   PubMed Web of Science ®Google Scholar
• Keyerleber M, McEntee M, Farrelly J, Thompson M, Scrivani P, Dewey C. 2015. Three-dimensional conformal radiation therapy alone or in combination with surgery for treatment of canine intracranial meningiomas. Vet Comp Oncol. 13(4):385–397.
   PubMed Web of Science ®Google Scholar
• Konradsson E, Arendt ML, Jensen KB, Børresen B, Hansen AE, Bäck S, Kristensen AT, af Rosenschöld PM, Ceberg C, Petersson K. 2021. Establishment and initial experience of clinical FLASH radiotherapy in canine cancer patients. Front Oncol. 11:658004.
   PubMed Web of Science ®Google Scholar
• Kruckman-Gatesy C, Ames M, Griffin L, Boss M-K, Rao S, Leary D, LaRue S. 2020. A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases. J Vet Cardiol. 27:62–77.
   PubMed Web of Science ®Google Scholar
• Kundapur V, Mayer M, Alexander A, Sidhu N, Zherebitskiy V, Auer R. 2020. Is immune modulation possible with radiation treatment?-report of a randomized phase III study irradiating canine de-novo brain tumors. Cureus J Med Sci. 12(4):a530.
   Google Scholar
• LaRue SM, Borak TB. 2016. The impact of a clinical electron accelerator on the advancement of veterinary oncology and translational cancer research. IEEE Trans Nucl Sci. 63(2):949–956.
   Web of Science ®Google Scholar
• LeBlanc AK, Breen M, Choyke P, Dewhirst M, Fan TM, Gustafson DL, Helman LJ, Kastan MB, Knapp DW, Levin WJ, et al. 2016. Perspectives from man’s best friend: national academy of medicine’s workshop on comparative oncology. Sci Transl Med. 8(324):324ps5.
   PubMed Web of Science ®Google Scholar
• LeBlanc AK, Mazcko CN. 2020. Improving human cancer therapy through the evaluation of pet dogs. Nat Rev Cancer. 20(12):727–742.
   PubMed Web of Science ®Google Scholar
• Lee BI, LaRue SM, Seguin B, Griffin L, Prebble A, Martin T, Leary D, Boss MK. 2020. Safety and efficacy of Stereotactic Body Radiation Therapy (SBRT) for the treatment of canine thyroid carcinoma. Vet Comp Oncol. 18(4):843–853.
   PubMed Web of Science ®Google Scholar
• Lempart M, Blad B, Adrian G, Bäck S, Knöös T, Ceberg C, Petersson K. 2019. Modifying a clinical linear accelerator for delivery of ultra-high dose rate irradiation. Radiother Oncol. 139:40–45.
   PubMed Web of Science ®Google Scholar
• Poulson JM, Vujaskovic Z, Gillette SM, Chaney EL, Gillette EL. 2000. Volume and dose–response effects for severe symptomatic pneumonitis after fractionated irradiation of canine lung. Int J Radiat Biol. 76(4):463–468.
   PubMed Web of Science ®Google Scholar
• Maeda S, Murakami K, Inoue A, Yonezawa T, Matsuki N. 2019. CCR4 blockade depletes regulatory T cells and prolongs survival in a canine model of bladder cancer. Cancer Immunol Res. 7(7):1175–1187.
   PubMed Web of Science ®Google Scholar
• Magestro L, Gieger T, Nolan M. 2018. Stereotactic body radiation therapy for heart-base tumors in six dogs. J Vet Cardiol. 20(3):186–197.
   PubMed Web of Science ®Google Scholar
• Martin TW, Griffin L, Custis J, Ryan SD, Lafferty M, Boss M-K, Regan D, Rao S, Leary D, Withrow SJ, et al. 2021. Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs. Vet Comp Oncol. 19(2):284–294.
   PubMed Web of Science ®Google Scholar
• Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y. 2016. Immunotherapy with a HER2-targeting listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase I trial in canine osteosarcoma. Clin Cancer Res. 22(17):4380–4390.
   PubMed Web of Science ®Google Scholar
• McChesney S, Withrow S, Gillette E, Powers B, Dewhirst M. 1989. Radiotherapy of soft tissue sarcomas in dogs. J Am Vet Med Assoc. 194(1):60–63.
   PubMed Web of Science ®Google Scholar
• McEntee MC, Page RL, Novotney CA, Thrall DE. 1993. Palliative radiotherapy for canine appendicular osteosarcoma. Veterinary Radiology & Ultrasound. 34(5):367–370.
   Web of Science ®Google Scholar
• Milner R, Salute M, Crawford C, Abbot J, Farese J. 2006. The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine. Vet Immunol Immunopathol. 114(3-4):273–284.
   PubMed Web of Science ®Google Scholar
• Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux P, Elbourne D, Egger M, Altman DG.; CONSORT. 2012. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 10(1):28–55.
   PubMed Web of Science ®Google Scholar
• Moirano SJ, Dewey CW, Haney S, Yang J. 2020. Efficacy of frameless stereotactic radiotherapy for the treatment of presumptive canine intracranial gliomas: a retrospective analysis (2014-2017). Vet Comp Oncol. 18(4):528–537.
   PubMed Web of Science ®Google Scholar
• Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, et al. 2016. Blocking indolamine-2,3-dioxygenase rebound immune suppression boosts antitumor effects of radio-immunotherapy in murine models and spontaneous canine malignancies. Clin Cancer Res. 22(17):4328–4340.
   PubMed Web of Science ®Google Scholar
• Nolan M, Dobson J. 2018. The future of radiotherapy in small animals – should the fractions be coarse or fine? J Small Anim Pract. 59(9):521–530.
   PubMed Web of Science ®Google Scholar
• Nolan MW, Gieger TL, Karakashian AA, Nikolova-Karakashian MN, Posner LP, Roback DM, Rivera JN, Chang S. 2017. Outcomes of spatially fractionated radiotherapy (GRID) for bulky soft tissue sarcomas in a large animal model. Technol Cancer Res Treat. 16(3):357–365.
   PubMed Web of Science ®Google Scholar
• Nolan MW, Green NA, DiVito EM, Lascelles BDX, Haney SM. 2020. Impact of radiation dose and pre-treatment pain levels on survival in dogs undergoing radiotherapy with or without chemotherapy for presumed extremity osteosarcoma. Vet Comp Oncol. 18(4):538–547.
   PubMed Web of Science ®Google Scholar
• Nolan MW, Kelsey KL, Enomoto M, Ru H, Gieger TL, Lascelles BDX. 2020. Pet dogs with subclinical acute radiodermatitis experience widespread somatosensory sensitization. Radiat Res. 193(3):241–248.
   PubMed Web of Science ®Google Scholar
• Nolan MW, Kent MS, Boss M-K. 2019. Emerging translational opportunities in comparative oncology with companion canine cancers: radiation oncology [Review]. Front Oncol. 9:1291.
   PubMed Web of Science ®Google Scholar
• Nolan M, Kogan L, Griffin L, Custis J, Harmon J, Biller B, Larue S. 2012. Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs. J Vet Intern Med. 26(4):987–995.
   PubMed Web of Science ®Google Scholar
• Nolan MW, Marolf AJ, Ehrhart E, Rao S, Kraft SL, Engel S, Yoshikawa H, Golden AE, Wasserman TH, LaRue SM. 2015. Pudendal nerve and internal pudendal artery damage may contribute to radiation-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 91(4):796–806.
   PubMed Web of Science ®Google Scholar
• Page R, Baneux P, Vail D, Duda L, Olson P, Anestidou L, Dybdal N, Golab G, Shelton W, Salgaller M, et al. 2016. Conduct, oversight, and ethical considerations of clinical trials in companion animals with cancer: report of a workshop on best practice recommendations. J Vet Intern Med. 30(2):527–535.
   PubMed Web of Science ®Google Scholar
• Panjwani MK, Smith JB, Schutsky K, Gnanandarajah J, O'connor CM, Powell DJ, Jr, Mason NJ. 2016. Feasibility and safety of RNA-transfected CD20-specific chimeric antigen receptor T cells in dogs with spontaneous B cell lymphoma. Mol Ther. 24(9):1602–1614.
   PubMed Web of Science ®Google Scholar
• Paoloni M, Khanna C. 2008. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer. 8(2):147–156.
   PubMed Web of Science ®Google Scholar
• Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WTN, Sparger EE, Rebhun RB, Monjazeb AM, et al. 2016. Canine cancer immunotherapy studies: linking mouse and human. J Immunother Cancer. 4(1):1–11.
   Web of Science ®Google Scholar
• Proulx DR, Ruslander DM, Dodge RK, Hauck ML, Williams LE, Horn B, Sylvester Price G, Thrall DE. 2003. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Vet Radiol Ultrasound. 44(3):352–359.
   PubMed Web of Science ®Google Scholar
• Regan DP, Coy JW, Chahal KK, Chow L, Kurihara JN, Guth AM, Kufareva I, Dow SW. 2019. The angiotensin receptor blocker losartan suppresses growth of pulmonary metastases via AT1R-independent inhibition of CCR2 signaling and monocyte recruitment. J Immunol. 202(10):3087–3102.
   PubMed Web of Science ®Google Scholar
• Rossmeisl JH. 2014. New treatment modalities for brain tumors in dogs and cats. Vet Clin North Am Small Anim Pract. 44(6):1013–1038.
   PubMed Web of Science ®Google Scholar
• Rowell JL, McCarthy DO, Alvarez CE. 2011. Dog models of naturally occurring cancer. Trends Mol Med. 17(7):380–388.
   PubMed Web of Science ®Google Scholar
• Schüler E, Trovati S, King G, Lartey F, Rafat M, Villegas M, Praxel AJ, Loo BW, Jr, Maxim PG. 2017. Experimental platform for ultra-high dose rate FLASH irradiation of small animals using a clinical linear accelerator. Int J Radiat Oncol Biol Phys. 97(1):195–203.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D.; CONSORT Group. 2010. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials. 11(1):32–38.
   PubMed Web of Science ®Google Scholar
• Thalmensi J, Pliquet E, Liard C, Chamel G, Kreuz C, Bestetti T, Escande M, Kostrzak A, Pailhes-Jimenez A-S, Bourges E, et al. 2019. A DNA telomerase vaccine for canine cancer immunotherapy. Oncotarget. 10(36):3361–3372.
   PubMedGoogle Scholar
• Thamm DH. 2019. Canine cancer: strategies in experimental therapeutics. Front Oncol. 9:1257.
   PubMed Web of Science ®Google Scholar
• Théon AP, Marks SL, Feldman ES, Griffey S. 2000. Prognostic factors and patterns of treatment failure in dogs with unresectable differentiated thyroid carcinomas treated with megavoltage irradiation. J Am Vet Med Assoc. 216(11):1775–1779.
   PubMed Web of Science ®Google Scholar
• Theon AP, Rodriguez C, Madewell BR. 1997. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation. J Am Vet Med Assoc. 210(6):778–784.
   PubMed Web of Science ®Google Scholar
• Tierce RM, Hughes K, Harrison L, Swancutt K, Rao S, Leary D, LaRue S, Boss MK. 2019. 2008 Response of canine soft tissue sarcoma to stereotactic body radiotherapy: establishing the preclinical model. In 65th Annual Meeting of the Radiation Research Society. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Seminars in radiation oncology.
   Google Scholar
• Timmerman RD. 2008. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol. 18(4):215–222.
   Google Scholar
• Vanpouille-Box C, Diamond JM, Pilones KA, Zavadil J, Babb JS, Formenti SC, Barcellos-Hoff MH, Demaria S. 2015. TGFβ is a master regulator of radiation therapy-induced antitumor immunity. Cancer Res. 75(11):2232–2242.
   PubMed Web of Science ®Google Scholar
• Vozenin M-C, De Fornel P, Petersson K, Favaudon V, Jaccard M, Germond J-F, Petit B, Burki M, Ferrand G, Patin D, et al. 2019. The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients. Clin Cancer Res. 25(1):35–42.
   PubMed Web of Science ®Google Scholar
• Vozenin M-C, Hendry JH, Limoli C. 2019. Biological benefits of ultra-high dose rate FLASH radiotherapy: sleeping beauty awoken. Clin Oncol. 31(7):407–415.
   PubMed Web of Science ®Google Scholar
• Walz JZ, Desai N, Van Asselt N, Poirier VJ, Hansen K, Selmic L. 2020. Definitive‐intent intensity‐modulated radiation therapy for treatment of canine prostatic carcinoma: a multi‐institutional retrospective study. Vet Comp Oncol. 18(3):381–388.
   PubMed Web of Science ®Google Scholar
• Warren SL, Whipple G. 1922. Roentgen ray intoxication: i. unit dose over thorax negative-over abdomen lethal. epithelium of small intestine sensitive to x-rays. J Exp Med. 35(2):187–202.
   PubMedGoogle Scholar
• Watts RH, Hopkins L, Trageser E, Dow S, Forthcoming BM. 2020. Microenvironmental immune effects of stereotacic body radiotherapy and immunotherapy in canine solid tumors. In 66th Radiation Research Society Annual Meeting.
   Google Scholar
• Yin Y, Boesteanu AC, Binder ZA, Xu C, Reid RA, Rodriguez JL, Cook DR, Thokala R, Blouch K, McGettigan-Croce B. Checkpoint blockade reverses anergy in IL-13Ra2 humanized scFv-based CAR T cells to treat murine and canine gliomas. Mol Ther Oncolytics. 11:20–38.
   Google Scholar